Skip to main content
[Preprint]. 2022 Jan 18:2022.01.14.476382. [Version 1] doi: 10.1101/2022.01.14.476382

Table 1.

Frequencies in non-Omicron SARS-CoV-2 genomes of non-synonymous mutations seen in the S-gene of BA.1.

Mutation Percentage of genomes in Oct 2021 Frequency rank out of 7202 mutations Selection Regime Relative frequency changes in VOC lineages (alternative amino acid state) Seen in other human beta CoV
α β γ δ
S/67V 0.435 85 Positive*
S/95I 16.047 21 Positive*
S/142D 0.002 5417 Positive*
S/212I 0.006 2814 Negative
S/339D 0.006 2883 Negative HKU1*
S/371L <0.005 >7202 Negative
S/373P 0.007 2719 Negative*
S/375F 0.003 4778 Negative
S/417N 0.529 73 Positive* (T) OC43
S/440K 0.156 216 Positive* ↑↑ (S)
S/446S 0.007 2666 Positive*
S/477N 2.038 35 Positive ↑↑ (I) ↑ (I) HKU1*
S/478K 32.32 13 Positive* SARS-1*
S/484A 0.004 3498 Positive* ↑ (K) (K) (K)
S/493R 0.007 2737 Neutral OC43
S/496S 0.013 1691 Neutral HKU1/OC43
S/498R <0.005 >7202 Negative
S/501Y 37.036 2 Positive*
S/505H 0.003 4099 Neutral
S/547K 0.013 1740 Positive
S/614G 98.97 1 Positive*
S/655Y 2.513 30 Positive
S/679K 0.041 534 Positive OC43*
S/681H 35.613 3 Positive* (R)
S/764K 0.005 3291 Negative
S/796Y 0.083 322 Positive SARS-1*
S/856K <0.005 >7202 Negative* OC43
S/954H <0.005 >7202 Negative
S/969K <0.005 >7202 Negative* HKU1*
S/981F <0.005 >7202 Neutral

Rows in bold indicate mutations at previously negatively selected or neutrally evolving sites. VOC columns track fold changes in mutation frequencies at corresponding sites in other VOCs (before and after boundaries are defined to create somewhat balanced sizes of sequence sets; the boundary is 2021/04/15 for α,β,γ and 2021/06/01 for δ). If another amino-acid residue is included in parentheses, then this residue has increased in frequency at the same site. ↑ - 2–10x fold increase ↑↑ - >10x fold increase. - lineage defining/majority mutation. (*) in other human beta-CoV - consensus residue in species matches the BA.1 residue; based on the sequence alignment from11